<?xml version="1.0" encoding="UTF-8"?>
<p>We took age adjusted vaccine efficacy estimates for each historical influenza season (2009/2010-2017/2018 inclusive) from publications detailing end-of-season seasonal influenza vaccine effectiveness in the United Kingdom [
 <xref rid="pcbi.1007096.ref028" ref-type="bibr">28</xref>â€“
 <xref rid="pcbi.1007096.ref034" ref-type="bibr">34</xref>]. In influenza seasons where equivalent publications were not available, we used mid-season or provisional end-of-season age adjusted vaccine efficacy estimates from PHE reports [
 <xref rid="pcbi.1007096.ref035" ref-type="bibr">35</xref>, 
 <xref rid="pcbi.1007096.ref036" ref-type="bibr">36</xref>].
</p>
